Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Guarnera

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|May 8, 2024
The metabolic fuel of paroxysmal nocturnal haemoglobinuriaLuca Guarnera, Valeria Visconte
Seminars in Hematology|March 2, 2024
TET2 mutation as prototypic clonal hematopoiesis lesionLuca Guarnera, Babal K Jha
Journal of Imaging|August 30, 2021
Fighting Deepfakes by Detecting GAN DCT AnomaliesOliver Giudice, Luca Guarnera, Sebastiano Battiato
Bioengineering (Basel, Switzerland)|October 28, 2023
Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging StrategiesLuca Guarnera, Carlos Bravo-Perez, Valeria Visconte
Seminars in Hematology|November 30, 2024
The potential promise of machine learning in myelodysplastic syndromeValeria Visconte, Jaroslaw P Maciejewski, Luca Guarnera
Biomedicines|May 25, 2024
Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant ProgressionSerena Travaglini, Massimiliano Marinoni, Valeria Visconte, et al.
Computers in Biology and Medicine|October 9, 2024
MITS-GAN: Safeguarding medical imaging from tampering with generative adversarial networksGiovanni Pasqualino, Luca Guarnera, Alessandro Ortis, et al.
International Journal of Molecular Sciences|November 9, 2024
Correction: Guarnera et al. <i>KMT2A</i> Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 9023Luca Guarnera, Matteo D'Addona, Carlos Bravo-Perez, et al.
International Journal of Molecular Sciences|August 29, 2024
<i>KMT2A</i> Rearrangements in Leukemias: Molecular Aspects and Therapeutic PerspectivesLuca Guarnera, Matteo D'Addona, Carlos Bravo-Perez, et al.
Cardiovascular & Hematological Disorders Drug Targets|June 16, 2024
Thrombosis in Myeloid Malignancies: From CHIP to AMLBeatrice Borsellino, Carlos Bravo-Perez, Valeria Visconte, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|May 8, 2024
The metabolic fuel of paroxysmal nocturnal haemoglobinuriaLuca Guarnera, Valeria Visconte
Seminars in Hematology|March 2, 2024
TET2 mutation as prototypic clonal hematopoiesis lesionLuca Guarnera, Babal K Jha
Journal of Imaging|August 30, 2021
Fighting Deepfakes by Detecting GAN DCT AnomaliesOliver Giudice, Luca Guarnera, Sebastiano Battiato
Bioengineering (Basel, Switzerland)|October 28, 2023
Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging StrategiesLuca Guarnera, Carlos Bravo-Perez, Valeria Visconte
Seminars in Hematology|November 30, 2024
The potential promise of machine learning in myelodysplastic syndromeValeria Visconte, Jaroslaw P Maciejewski, Luca Guarnera
Biomedicines|May 25, 2024
Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant ProgressionSerena Travaglini, Massimiliano Marinoni, Valeria Visconte, et al.
Computers in Biology and Medicine|October 9, 2024
MITS-GAN: Safeguarding medical imaging from tampering with generative adversarial networksGiovanni Pasqualino, Luca Guarnera, Alessandro Ortis, et al.
International Journal of Molecular Sciences|November 9, 2024
Correction: Guarnera et al. <i>KMT2A</i> Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 9023Luca Guarnera, Matteo D'Addona, Carlos Bravo-Perez, et al.
International Journal of Molecular Sciences|August 29, 2024
<i>KMT2A</i> Rearrangements in Leukemias: Molecular Aspects and Therapeutic PerspectivesLuca Guarnera, Matteo D'Addona, Carlos Bravo-Perez, et al.
Cardiovascular & Hematological Disorders Drug Targets|June 16, 2024
Thrombosis in Myeloid Malignancies: From CHIP to AMLBeatrice Borsellino, Carlos Bravo-Perez, Valeria Visconte, et al.
Pageof 5